Targeted collection design
Design a tailored collection of synthesizable molecules for your target (from hundreds to thousands of molecules) ranked by affinity, selectivity, ADMET ready to synthetize and incorporate to your screening collection.
Virtual library expansion from confirmed hits
Hit Identification Follow-Up. Generate virtual libraries of novel molecules inspired by your hits based on vast chemical collections. Explore diverse chemical modifications while optimizing potency, selectivity and drug-like properties, customizable to your expectations.
Iterative DMTA optimization with experimental integration
Hit-to-Lead Optimization with Experimental Feedback. Incorporate your experimental results into the predictions based on KAMPAÏ Explainable AI and Active Learning in a Design-Make-Test-Analyse (DMTA) design process, while ensuring proposed molecules are synthesizable and available from commercial suppliers.
How we work
01
Legal Agreement
Define collaboration terms and risk-sharing levels, with Go/No-Go decisions at key milestones.
02
Data Sharing
You provide target information, screening data, hit structures, and potency results.
03
Target Profile Definition
Together we agree on the desired molecule profile (potency, selectivity, ADMET).
04
AI-Driven Optimization
In silico AI design, analysis, and delivery of molecules in a DMTA process.
05
Experimental Validation
You test the proposed molecules, feeding results back into KAMPAÏ for continuous optimization.

